Hyperlipid by Petro Dobromylskyj

05 February 2023

You need to get calories from somewhere, should it be from carbohydrate or fat?
  • Delta psi and insulin and ROS

    The hypothesis paper

    New Control of Mitochondrial Membrane Potential and ROS Formation – A Hypothesis

    mentions some factors which might flood mitochondria with Ca2+. Vasopressin gets a mention, again an excellent pressor drug for intractable hypotension, if you don't mind the calcium.

    But of course the hormone we all want to ask about is insulin. So you go to Pubmed and search on "insulin calcium ROS"

    which brings up this as pretty much the first hit


    I haven't read the paper, all I wanted to know was whether insulin behaved as a "stress" hormone as regards Ca2+:

    "The insulin-dependent Ca(2+) released from IP3R of skeletal muscle also promotes mitochondrial Ca(2+) uptake."

    A lot of cautions yet again. It's neural tissue, which is not a typical insulin sensitive tissue and the paper is old enough that measuring mitochondrial membrane potential was a bit more difficult than ordering a fluorescent dye kit form some generic laboratory supply company.

    However it does seem that in something resembling real cells that insulin not only increases delta psi but it also increases ATP levels. Of course we don't know whether the extra ATP comes from glycolysis or increased ox phos from this paper. We do know that it increases.



















    The insulin concentration used here is 1.0nM which is essentially equivalent to maximal physiological concentration in the aftermath of a meal of modern junk food. Here is the pattern of mitochondrial hyper polarisation at exposure to increasing insulin concentrations. Using 0.75nM is absolutely physiological (if you eat junk food). The glucose used appears to be in the region of 10mM (Ham's F12 medium) and the medium is serum (ie fatty acid) free:



















    Certain things are clear. There is no dose-response to insulin. Even physiological levels produce a maximal rise in membrane potential. If the pre-insulin membrane polarisation is around 100mV (the technique to assess polarisation couldn't give an absolute value in 2004) then insulin will double this. That seems pretty well certain to generate a membrane polarisation well over the 140mV which will generate copious ROS.

    Next thing from here (again)


    is that insulin signaling, as assessed by the proportion of Akt which is phosphorylated, is also maximal at exposure to insulin at modestly greater than peak physiological levels (here insulin at 5nM with glucose at ~5mM, some bovine serum and glutamate):














    This leaves me with an unanswered question.

    We know that we can increase Akt phosphorylation during massively supra-physiological insulin exposure by simply limiting delta psi with agents such as BAM15 or DNP. This is because we limit the ROS generation which is needed to induce insulin-induced insulin resistance, allowing a little extra pAkt to be formed before ROS exceed a critical threshold. We also know that DNP at in-vivo concentrations does the opposite, it reduces insulin signaling. I won't  re-cite the same old papers. 

    What I would like to know is what the oxidation of linoleic acid does to pAkt levels under physiological insulin exposure, compared to palmitic acid. If it is the generation of ROS which limits the rise in pAkt then the lower ROS generation under linoleic acid oxidation should allow more pAkt formation, with enhanced insulin signalling under physiological conditions, which is essential for the development of obesity.

    One of my core tenets is that LA limits the normal resistance to insulin signaling mediated by ROS generation. My opinion is the LA causes insulin resistance only once insulin signaling augmentation has produced distended adipocytes which release FFAs in the face of elevated insulin/glucose. In the pre-obese state LA facilitates insulin signaling. Otherwise you wouldn't get fat.

    To my knowledge no one has looked at Akt phosphorylation when specific fatty acids are being metabolised under reasonably physiological insulin and glucose concentrations. It would be great to know if LA allowed more pAkt to be formed.

    I'd guess that this would be the case.



    I have a few more speculations about FFAs, glucose/insulin and ROS which I might leave for another post as this one is getting unwieldy, yet again.

    Peter
  • Complex IV and control of delta psi
    There was a time, quite early in my anaesthesia training, when we used to use a calcium infusion to support blood pressure in anaesthetised horses. You got a bottle of calcium borogluconate marketed for treating milk fever in cattle, hooked it up to a giving set and chose a ball park drip rate by eye. It was bloody effective, easy to use and dirt cheap.

    Then we learned a bit more about the role of Ca2+ in cell death and stopped doing it. It's still worth thinking about why it worked.

    I have accepted various concepts about the acute control of delta psi and ROS production when metabolic substrate is supplied in excess of metabolic needs. The basic idea is that a replete ATP pool allows delta psi to rise and generate ROS. The earliest ref I've got in support of delta psi and ROS comes from Skulachev in the late 1990s.

    High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria

    This is not a physiological model, it just looks at how manipulating delta psi with substrate/inhibitors controls ROS generation. Peak delta psi specified on the graph with their voltage sensitive dye appears to be around 170mV.





















    The peak values of delta psi and ROS generation are under succinate oxidation and delta psi is modified using either an uncoupler or complex II inhibitor, so, as so often, we are a long way from physiology here but the general principle that ROS generation rises rapidly above a threshold delta psi appears to hold good today. Currently the rise in ROS is thought to occur at around 140mV. Next we can think about the control of ATP synthesis by complex IV, synonymous with cytochrome c oxidase.

    This is an interesting review/hypothesis paper from 2001 but I think it too is now quite well accepted:


    Peter Mitchell's original concept, to which I have long-term "subscribed", was that electrons passed down the ETC to oxygen, generating a proton gradient, which generates ATP via ATP synthase. If the proton gradient becomes high enough it is no longer possible for electrons to force the extrusion of any more protons (or to be able to flow down the ETC to oxygen) so respiration slows. This appears to be real and to happen at a membrane voltage of 140-200mV. I've extracted the two components of Figure 4 in to separate graphs for a clearer discussion.

    Like this:


















    The red line is the rate of respiration through complex IV as a function of the delta psi generated. As the membrane voltage increases ATP synthase starts turning at around 60mV (the blue line). At just over 100mV ATP synthase activity is maximal and doesn't increase with increasing membrane voltage (in this model). What does increase are those aforementioned ROS generated above 140mV. 

    Summary so far: The very high membrane voltages needed to inhibit respiration at complex IV will cause excess ROS generation. This is on the border between physiology and pathology.

    There is a second system to control respiration through complex IV. This system monitors the ATP:ADP ratio and limits respiration (and membrane voltage to minimal ROS generating levels) based on rising ATP levels. Like this:


















    The blue line of ATP synthase activity is unchanged. The green line of respiration though complex IV, as soon as ATP synthase starts to generate ATP, begins to drop and limits respiration though complex IV with a maximum membrane potential at around 120mV, well below that 140mV needed for ROS generation.

    So we can limit respiration by inhibiting complex IV using this system at a membrane potential below 140mV with limited ROS generation or we can inhibit it at above 140mV accepting ROS generation using the Mitchell concept. Both are available.

    Physiology "chooses" which system to use depending on the circumstance it is presented with. Neither is an "accident". The behaviour of complex IV is determined by it's phosphorylation state. Mostly it's phosphorylated and so behaves like the green line from the second graph and ROS are minimised.

    If you strip away the phosphates from complex IV it behaves like the red graph and allows a membrane potential of 140-200mV, with associated ROS generation:

    "The allosteric ATP inhibition of cytochrome c oxidase is switched on by cAMP-dependent phosphorylation and switched off by [Ca2+]-induced dephosphorylation of the enzyme (Bender and Kadenbach, 2000)."

    That's right: Ca2+ ions dephosphorylate complex IV to allow respiration to proceed to a higher membrane voltage with the acceptance of high ROS generation. The gain appears to be the ability to generate more ATP under "stress" situations and this is primarily under hormonal control. Hormonal control is interesting to look at in another post. But for now:

    My bottle of calcium borogluconate was stripping phosphates off of complex IV to allow more ATP production in a myocardium poisoned with an inhalation anaesthetic agent, halothane back in the day. The cost would be increased ROS and it's probably a good idea that we stopped doing it.

    Peter
  • Transformer p245 and onwards: glutathione
    In Transformer Nick Lane has an interesting discussion of the roles of glutathione in redox chemistry. He seems to have been spurred to look at this when his research group had a WTF moment with fruit flies. They've not published the work yet so Transformer is the only place to read about it.

    They had highly, highly inbred (identical) fruitflies with respect to nuclear genes. They maintained them as identical as possible. Different strains had mitochondria with minor variations in mtDNA, within normal limits, but with differences of "fit" to the (all identical) nuclear genome. Some combinations gave better ETC characteristics than others.

    To see if the variations in function were due to ROS flux they treated the flies with n-acetyl-cysteine, a glutathione precursor, producing an excellent scavenger of ROS. You know:


    2G-SH  +  H2O2  ->  G-S-S-G  + 2H2O


    and all should be well, or at least better.

    That didn't work out too well. Males were more or less OK. Most females were "seedy" on NAC. In one strain all of the females, only, died. They checked glutathione levels and the NAC appeared to be doing what it was supposed to do, lots of glutathione.

    Lane's idea, which is rather insightful as regards life, is that a body will tolerate an ROS flux within certain limits. To limit excessive ROS formation cells are willing to limit oxidative phosphorylation by deactivating complex I. Compromising ATP production is considered acceptable in order to limit ROS generation to "tolerable" limits.

    This is not really surprising. If we think about uncoupling proteins their core function is to dissipate delta psi to a voltage which will not generate many ROS (less than ~140mV), at the cost of decreased ox-phos.

    At a guess you might be able to limit/localise the glutathiolation effect to those proteins which are responsible for excess ROS, so glutathione glutathiolates the cysteines within said protein (in this example complex I) in proportion to ROS being generated. Like this


    G-SH  +  Prot-SH  +  H2O2  ->  G-S-S-Prot  +  2H2O


    Glutathiolation has evolved to alter the function of a protein in such a manner as to decrease ROS generation, even if that includes a decrease in oxidative phosphorylation.

    Lane's guess is that female flies, with their high demand for ATP for egg production, couldn't cope with the drop in ox-phos mediated by glutathiolation of complex I.

    These flies died in order to limit ROS production.

    Have I ever mentioned that ROS are central to, well, everything?

    Peter

    Supplementary thought: Perhaps we could better phrase it that oral NAC raises glutathione to levels in excess of those which are already ideal, so hyper-glutathiolation causes death by excess ox-phos limitation. This would be particularly problematic for flies with slightly more ROS generation than others. The flies were okay provided ROS and glutathiolation of complex I were at physiological appropriate levels.

    Fascinating in view that NAC/glutathione appears to be a pretty Good Drug in general terms. But, as always, over riding evolution has costs.
  • Faking it with selenium

     I've looked at this paper in the past, here and here and it is, to say the least, a little dubious in places

    High selenium impairs hepatic insulin sensitivity through opposite regulation of ROS

    and I really, really want it to be genuine because it supports this hypothesis

    High selenium -> high ROS scavenging -> impaired insulin signalling   -> adipose lipolysis

    A follow on from this, also plausible, is that

    High adipose lipolysis -> excess FFAs to liver -> hepatic ROS from beta oxidation -> hepatic insulin resistance

    which would be normal under high FFA oxidation in hepatocytes. I'm willing to accept that reducing ROS in adipocytes might increase ROS in hepatocytes, at a push. But...

    These are images taken of hepatocytes from recently euthanased rats fed supplementary selenium for six weeks. This is section A from Figure 3 as a simple copy paste:



















    What we are comparing is the colour intensity of MitoSOX, a marker of ROS generation,  between control square and the HSe, high selenium square. These two:



















    Control is essentially black, ie no ROS production and HSe is red, lots of ROS production. Let's cut out the intermediate LSe row and abutt the HSe to the control to make this as obvious as possible:



















    Now I have another problem. The bright blue colour is an Hoechst stain developed to show DNA, ie it shows the nuclei. I would expect the same intensity of staining with Hoechst stain irrespective of exposure to selenium for 6 weeks or not. The control Hoechst stain is dull in the control while in the HSe image it is bright. Perhaps there has been a problem with the photography?



















    I can help out by simply increasing the exposure factor for whole of the control row using the colour adjustment in Preview software. This is what it looks like:



















    Which makes for an interesting comparison between the MitoSOX fields at this (???corrected???) exposure/brightness:



















    I defy anyone to see any difference between the control MitoSOX intensity and the high selenium exposure MitoSOX intensity. Which makes the rest of the paper, attempting to explain this non-finding, of little value.

    So what do I make of this table:




    showing a clear dose response to sodium selenite supplementation in both bodyweight and fat weight? For someone who thinks that markedly reducing ROS in adipocytes should cause lipolysis this is exactly what you would expect.

    Bear in mind that these rats were gavaged with selenium, it wasn't in the food, there is no "palatability" issue.

    I think this is real. Why? Because I want it to be and because of this paper


    which found exactly the same effect. This is food intake per week:











    The results for weight gain are exactly as expected from the food intake and are given in Table 4, which is huge and turned on its side over two pages. You need a VPN and a line to a server facilitated from Kazakhstan or just take my word for it, food intake predicts final weight, this time.

    This is explained away by the authors using ad hoc hypothesis number 12,352 thus:

    "A reduced dietary intake was noted throughout the observation period for all treatment groups, which may be considered as a consequence of the unpalatability of the dietary mixture. This resulted in a decreased bodyweight gain in all treatment groups, particularly the females."

    I guess, if you were dumb enough, you could call this "reverse Reward". No sniggering!

    Combining parts of both papers leaves me deeply embedded in my own confirmation biases, which make sense, at least to me.

    ROS are fundamental.

    Peter
  • BAM15 and semaglutide are not insulin sensitising

    I'm interested in how an uncoupling agent, which works by limiting ROS generation from the mitochondrial inner membrane, can be described as being insulin sensitising while causing fat loss. This clearly doesn't make sense: anything which increases insulin signalling should increase insulin action. A core action of insulin is the storage of lipid. Fat loss is synonymous with reduced insulin signalling.

    This next paper

    BAM15‐mediated mitochondrial uncoupling protects against obesity and improves glycemic control

    is one I've talked about before. Today I would like to examine Figure 3 in some detail. This work was done using C2C12 myotubes as muscle surrogates and, as far as I can make out from the methods, the DMEM is high glucose, 25mmol/l when fresh, and changed every other day.

    The core marker for insulin signalling in the study was the phosphorylation of AKT, shown in graph B of pAKT 10 minutes after exposure to insulin:


















    I think we can accept that insulin increases the phosphorylation of AKT, blue columns, but there is only a relatively weak dose response in normal C2C12 myotubes. The pink columns show the effect of 16 hours of pre-incubation with BAM15 before exposure to insulin for 10 minutes. I think we can see a reasonable dose response this time with the highest dose of insulin giving the greatest pAKT increase.

    Conclusion: Pre-incubation with BAM15 increases pAKT, a good indicator of insulin signalling. Ergo BAM15 is insulin sensitising.

    Well, maybe.

    Now it's time to re-label graph B. Digging back in to one of Kevin Hall's papers I found that peak insulin in a normal human being after a high carbohydrate meal was in the region of 1000pmol. So we have 0.5micromol insulin as a 500 times peak physiological value and 1.0micromol is 1000 times peak physiological.


















    Let's be clear. If we use 1000 times peak human physiological insulin we can further increase the action of insulin to phosphorylate AKT by preincubating with the uncoupler BAM15. Clear cut.


    Next we should re-visit insulin-induced insulin resistance from back in 2018 and this paper:

    Insulin Resistance Induced by Hyperinsulinemia Coincides with a Persistent Alteration at the Insulin Receptor Tyrosine Kinase Domain

    and have a look at Figure 2, graph C, which looks like this













    I've added the insulin concentrations, this time in nanomoles, which makes it simple to realise we are looking at 5x, 17x or 170x peak physiological insulin exposure.

    Core concept: You cannot increase pAKT above that of modestly supramaximal (5x grey squares) by increasing insulin exposure to lethal overdoses, be that 170x physiological here (black squares) or 1000x physiological as in the BAM15 study. Particularly at the 10 minute mark.

    Unless you pre-treat BAM15.

    My conclusion is that BAM15 increases the level of pAKT induced by massively supramaximal insulin by reducing insulin-induced insulin resistance.  This means that the normal physiological resistance to excessive insulin exposure, ie the refusal to respond further, is blunted. So pAKT goes up.

    Again, to clarify: Excessive insulin signalling leads to insulin-induced insulin resistance. BAM15 *reduces* insulin signalling allowing a massive excess of insulin to do a little more phosphorylation of AKT before resistance kicks in. This is a direct consequence of reduced insulin signalling plus supra maximal insulin exposure.

    If we were to look at pAKT under conditions of therapeutic uncoupling, it would be decreased. No one in their right mind would do such a study because it would not fit in with the paradigm that insulin sensitisation is a Good Thing. But, if you look hard enough, you can find papers which report this correct finding almost accidentally...

    Old stuff again from a blog post last year citing a study from 2015

    The Mitochondrial Uncoupler DNP Triggers Brain Cell mTOR Signaling Network Reprogramming and CREB Pathway Upregulation

    The study used therapeutic levels of DNP (the mice didn't die!) to uncouple the mitochondria of brain cells exposed to physiological concentrations of insulin (ie produced by eating crapinabag mouse chow):

    "The protein levels of AKT, p-AKT (Thr308), ERK, and p-ERK were examined by immunoblotting which showed that the activated (phosphorylated) forms of these kinases (p-AKT and p-ERK 42/44) were reduced in the cerebral cortex at 24 and 72 h after DNP treatment (Fig. 3c–e). Collectively, these results suggest that insulin receptor signaling is suppressed in cerebral cortical cells in response to mild mitochondrial uncoupling."

    Aside: I can do exactly the same analysis using metformin. Using a lethal dose of metformin combined with a lethal doses of insulin results in increased peak pAKT.


    discussed here giving a therapeutic dose of metformin to a real live human with genetically limited insulin signalling. It reduces their ability to insulin signal still further (and pisses them off big time).


    End aside.

    BAM15 or DNP (or metformin) all work therapeutically to reduce insulin signalling in vivo. This blunts the insulin signalling needed for insulin-induced insulin resistance in vitro which allows a modest increase in pAKT under massive insulin overdose. Therapeutically this reduced insulin signalling allows lipolysis and fat loss.

    Ultimately life has to make sense. Mostly it does.

    Oh, and semaglutide with its induction of UCP-1 gene expression is no more insulin sensitising than BAM15. Otherwise it wouldn't give fat loss!

    Peter